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Introduction: Microcephaly is characterized by a smaller than normal head circumference. Recently, 
Zika virus (ZV) has been associated with microcephaly.
Objective: To describe the prevalence of microcephaly in Colombia taking as the baseline the 
information from the period before the Zika virus infection epidemics.
Materials and methods: We reviewed Medline, Scopus, Scielo, Lilacs and annual reports of congenital 
malformation monitoring systems across Latin America, among others sources, for articles published 
before April, 2015, reporting the prevalence of microcephaly in Colombia between 1982 and 2013.
Results: We identified 32 non-duplicate articles; we selected 25 articles for revision of which 12 met 
the criteria for inclusion in the systematic review, including 2,808,308 births.
Conclusions: The prevalence of microcephaly in Colombia from 1982 to 2013, before the introduction 
of ZV, ranged from 0.3 to 3.1 per 10,000 births, with an average of 1.8 (95% CI 1.7-1.8) per 10,000 
births. These findings are important to determine if the prevalence after the introduction of the Zika virus 
infection registered significant changes. 
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Microcefalia en Colombia antes de la epidemia del Zika: revisión sistemática de la literatura
Introducción. La microcefalia consiste en una circunferencia cefálica menor de la esperada. 
Recientemente, el virus del Zika se ha asociado con esta condición.
Objetivo. Describir la prevalencia de la microcefalia en Colombia, estableciendo como línea de base 
el periodo anterior a la epidemia del virus del Zika.
Materiales y métodos. Se revisaron las bases de datos Medline, Scopus, Scielo, Lilacs y el reporte 
anual de malformaciones congénitas en Latinoamérica, así como otras fuentes publicadas antes de 
abril de 2015 con los datos de prevalencia de la microcefalia en Colombia entre 1982 y 2013.
Resultados. Se detectaron 32 artículos no duplicados, se revisaron 25 y se seleccionaron 12 que 
cumplían con los criterios de inclusión para la revisión sistemática, los cuales registraban 2’808.308 
nacimientos.
Conclusiones. La prevalencia de la microcefalia en Colombia entre 1982 y 2013, antes de la epidemia 
del virus del Zika, oscilaba entre 0,3 y 3,1 por 10.000 nacimientos, con un promedio de 1,8 (IC95% 1,7-
1,8). Este dato es importante para determinar la diferencia en la prevalencia después de la introducción 
del virus del Zika en Colombia.
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The most common defects found in newborns in 
South America are cardiac alterations (28 per 
10,000 live births), defects of the neural tube 
closure (24 per 10,000 live births), Down syndrome 
(16 per 10,000 live births), cleft lip and cleft palate 
(15 per 10,000 live births), and defects of the 
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abdominal wall (4 per 10,000 live births) (1). Some 
congenital defects, such as microcephaly, are 
reported less frequently due to their low prevalence. 
Given the introduction of Zika virus (ZV), however, 
microcephaly has gained clinical relevance.
Microcephaly is an important neurological mani-
festation that may result from insults to early brain 
development. It is part of the hundreds of genetic 
syndromes (2) and it has been variably defined 
in the literature. The World Health Organization 
(WHO) defines microcephaly as a head circum-
ference less than two standards below the median 
for age and sex, and severe microcephaly as 
a head circumference less than three standard 
deviations below the median for age and sex (3). 
One study reported that approximately 61% of 
children with a head circumference less than two 
standard deviations have no abnormal findings 
on evaluation with imaging techniques (4). When 
imaging techniques reveal brain malformations, 
the following findings have been documented: Ven-
tricular dilatation, mild atrophy (31%), moderate to 
severe atrophy with ventricular dilation (28%), and 
isolated parenchymal abnormalities (2%) (4). Other 
studies using magnetic resonance imaging (MRI) 
have reported the presence of brain abnormalities 
in 67-80% patients with microcephaly (5,6). MRI is 
the most sensitive diagnostic tool for the evaluation 
of microcephaly.
Microcephaly may be congenital or postnatal (7), 
which means a failure in brain growth after birth. It 
is also described as syndromic or primary (known 
as vera microcephaly). This classification depends 
on the presence or absence of extra-cranial malfor-
mations or facial dimorphism (2). Microcephaly is 
sometimes the first sign of a congenital condition, 
a genetic anomaly or an acquired problem (due to 
congenital infection) (8). Genetic causes have been 
reported in approximately 15.5% to 53.3% of cases. 
The prevalence of metabolic disorders is unknown, 
but it is estimated to be 1% to 5%. The conditions 
associated with microcephaly include epilepsy 
(40%), cerebral palsy (20%), intellectual disability 
(50%) and eye problems (20-50%) (2). A diagnosis 
of microcephaly has serious clinical implications, 
as there is a direct correlation between the degree 
of microcephaly and the degree of intellectual 
disability (9).
Since the end of 2015, microcephaly has received 
global attention due to the ZV epidemic in the 
Americas. Different criteria for causality have 
been established, including a spatial-temporal 
relationship and biological plausibility that entails 
identification of ZV in the brain tissue of affected 
fetuses (10). Animal models have been developed 
to try to provide a pathophysiological explanation 
for microcephaly via congenital infection with 
the virus (11). In February 2016, the first case 
of intrauterine transmission of ZV was reported, 
which featured neurological malformations in the 
fetus (12). In the months following the emergence 
of ZV in Brazil, an annual increase of up to 20 times 
the number of cases of birth defects has been 
reported, with a marked increase in microcephaly 
in particular (13). In 2015, 1,248 new suspected 
cases of microcephaly were reported in Brazil, 
with a prevalence of 99.7 per 100,000 live births. 
With these observations, the Brazilian Ministry 
of Health confirmed the relationship between 
ZV and microcephaly (14). Subsequently, WHO 
declared an epidemiological alert regarding ZV 
and its association with congenital malformations 
and neurological syndromes (15). Thus, ZV and 
its association with birth defects have recently 
become a public health problem of international 
importance (16).
So far, associative epidemiological links exist 
between ZV and microcephaly. This has resulted 
from the increase in the number of newborn infants 
with microcephaly (13,17) in countries where there 
is a high rate of suspected and confirmed cases of 
infection by ZV (18). Some hypotheses suggest that 
the teratogenic mechanisms of ZV are associated 
with the precipitation and deregulation of retinoic 
acid-dependent genes, extending the sequences 
in the genome that are closely involved with the 
development of the brain. This mechanism is known 
to be associated with other neurotropic viruses. 
For this reason, the spectrum of malformations 
generated by hypervitaminosis A presents with 
an embryopathy that appears similar to that of ZV 
(19,20). Other researchers suggest a direct immune 
effect of the virus on neuronal cells as demonstrated 
in animal models where the high replication rate of 
ZV in progenitors of neuronal cells, which have a 
high concentration of viral receptors, is suggested 
to be the gateway to the entrance of the virus to the 
brain. Immunoreactivity with markers associated 
with cell death, such as caspases, leads to apoptosis 
of these cells and pyramidal corticospinal neurons, 
which ultimately generate the appearance of micro-
cephaly as an external feature (21).
In Colombia, there were 657,126 reported cases 
of infection by ZV from April to June, 2016. Four 
percent of these cases were confirmed by PCR. 
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The infection rate was two times higher in women 
than in men. Within this infected population, 11,944 
pregnant women were reported, with 12% of these 
ZV cases confirmed by PCR; 90% of pregnant 
women who reported this infection gave birth to 
children with no apparent abnormalities. Fifty new-
borns were reported with possible microcephaly; 
26 of these cases are still being investigated, while 
20 have confirmed congenital defects that caused 
genetic and neural tube defects. Of these patients, 
four have evidence of congenital ZV infection 
that presents with microcephaly and without co-
infections (22). It is important to understand the 
prevalence of microcephaly in Colombia in the 
years prior to the ZV epidemic in order to have 
a starting point to establish comparisons after its 
arrival to Colombia and assess its possible involve-
ment in birth defects of the central nervous system, 
such as microcephaly.
In order to assess the prevalence of microcephaly 
in Colombia prior to the ZV epidemic, we con-
ducted a systematic review of the literature. Articles 
included for consideration in the present study 
were those that addressed Colombian patients with 
microcephaly, as reported between 1982 and 2013. 
The primary outcome studied was the prevalence 
of microcephaly in Colombia during this period. The 
secondary outcome was the prevalence of birth 
defects of the central nervous system in Colombia 
during the period.
Materials and methods
The protocol for the systematic review was regis-
tered in the United Kingdom National Institute of 
Health and Research International Prospective 
Register of Systematic Reviews (PROSPERO) as 
number 48859. 
The objective of the systematic review was to deter-
mine the prevalence of birth defects in Colombia 
from 1982 to 2013. Articles published in Spanish, 
English, and Portuguese were included. The inclu-
sion criterium was cross-observational studies 
that determined the prevalence of birth defects in 
Colombia, including microcephaly as defined by 
the Latin American Collaborative Study of Con-
genital Malformations (ECLAMC). We excluded 
articles in which the diagnosis was done during the 
prenatal period, due to the absence of confirmation 
of microcephaly in these studies. The outcomes 
measured were the prevalence of microcephaly 
and the prevalence of central nervous system birth 
defects in Colombia between 1982 and 2013.
The search of the literature was performed in the 
different international, Latin American and national 
(Medline, Scopus, Science Direct, Lilacs, Dare, 
Bireme, and Cochrane) databases. The following 
Medical Subject Headings (MeSH) search terms 
were used: “birth defects,” “microcephaly,” “preva-
lence,” and “Colombia.” Additional Latin American 
and national data were obtained from the annual 
reports of the epidemiological surveillance of con-
genital malformations for articles published before 
April, 2015; the last search was performed in October, 
2016. We searched for additional literature in the 
references reported in indexed articles. Moreover, 
some authors were contacted for additional sources 
of information. The eligible study designs included 
cross-sectional observational studies, cohort, case-
control, ecological, and reports of the epidemiologi-
cal surveillance of congenital malformations.
Articles and abstracts were examined indep-
endently by two reviewers in order to select those 
to be considered for complete text review based on 
the inclusion and exclusion criteria and, in case of 
disagreement, a third reviewer assessed the article 
and the decision was made by consensus. The 
data collected from each study were the number of 
cases of microcephaly, the period of time studied, 
the number of births and the number of defects of 
the central nervous system.
The limitations of the study include the fact that the 
definition of microcephaly varies in the literature. 
The definition used for data collection in this study, 
as well as in the majority of the reviewed articles, 
was head circumference less than three standard 
deviations of the mean for age and sex. To control 
this selection bias, we included studies performed 
in institutions using the ECLAMC criteria, since the 
institutions using this surveillance system feature 
a greater sensitivity, uniformity, and coverage of 
defects compared to those monitored by the sur-
veillance system (Sistema de Vigilancia en Salud 
Pública, Sivigila) of the Instituto Nacional de Salud 
(23). In addition, another possible risk of bias was 
the failure to include a study in which microcephaly 
was evaluated. Therefore, we designed a system 
for searching those articles in which databases 
were searched and, subsequently, references in the 
articles found in order to minimize the loss of data. 
Data analysis
We collected the data from eligible studies con-
sidering the study design, year of publication, 
authors, area, and period of the study. The following 
information was extracted from each article: The 
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total number of malformations, the number of 
cases of microcephaly reported, the number of 
nervous system malformations, and the number 
of births in the period studied. These data were 
then combined and used to calculate the rates per 
10,000 live births. In order to avoid repeating data, 
if the participants were included in more than one 
study, only the study with the greater sample size 
was included. 
Results
Using the MeSH terms defined in the methodology, 
32 articles were identified in the different data-
bases, references and monitoring systems of 
national birth defects. Initially, the repeated articles 
were excluded, and after filtering the articles and 
applying the inclusion and exclusion criteria, 28 
articles were eligible, of which 12 were included 
in the review since they accomplished the primary 
and secondary objectives of the research (figure 1).
The studies reviewed were published between 
2003 and 2015 in Brazil and Colombia, all using 
data from Colombia. The period evaluated included 
2,808,308 births, 21,363 malformations, 1,680 neu-
rological malformations and 420 cases of micro-
cephaly (table 1).
During the period evaluated, the surveillance 
system (Sivigila) of the Instituto Nacional de 
Salud was started started. In 2009, a pilot test 
was developed and an annual report for the 2010 
period was published. During the period 2010-
2013, there were 2,655,796 births, of which 0.35% 
had defects of some kind, including 1,248 reported 
malformations of the central and peripheral ner-
vous system, which corresponded to an average of 
15.8% of all congenital malformations reported, with 
a prevalence of 4.85 per 10,000. Of these, 3.38% 
corresponded to microcephaly, with an average 
prevalence of 1.17 cases per 10,000 births (table 2).
The prevalence of birth defects in the country 
varied between 8.7 and 68.9 per 10,000 live 
births from 2010 to 2013 according to Sivigila, 
an increase directly related with the coverage of 
this program nationwide. The highest reported 
rate of birth defects came from Bogotá, reaching 
430.8 per 10,000 births. The lowest rate came 
from the department of Risaralda, reported as 
89.8 per 10,000 births. The highest prevalence of 
microcephaly reported was from Bogotá, reaching 
27 titles found from
database searches
5 titles found from
other sources 
28 articles after eliminating duplicates
28 articles assessed
16 articles reviewed
12 excluded
Excluded with reason (4)
- Absence of results
- Repeated database use
- Study design
12 articles included for
qualitative analysis
Table 1. Prevalence of microcephaly and central nervous system anomalies per 10,000 births in Colombia
Author, publication year, study period, study location Microcephaly Central nervous system 
anomalies
Number of 
cases
Number per 
10,000 births
Number of 
cases
Number per 
10,000 births
González Y, 2010, 2010, Colombia 21 00.3 128   2.0
González Y, 2011, 2011, Colombia 70 10.1 346   5.2
González Y, 2012, 2012, Colombia 74 10.1 237   3.5
Misnaza SP, 2013, 2013, Colombia 142 20.2 573   8.7
Pachajoa H, 2010,2004-2008, Cali, Colombia 5 10.5 114 34.6
Silva JR, 1998, 1987-1988, Barranquilla, Colombia 1 20.7   10 26.6
Ramírez J, 2015, 2011-2012, Cali, Colombia 2 00.5   28 49.4
López JS, 2015, 1982-2013, Colombia 77 30.1 ND ND
García H, 2003, 1997-2000, Bogotá, Colombia 2 30.5   31 54.5
Porras GL, 2016, 2010-2013, Risaralda, Colombia 13 30.1   73 17.2
Zarante I, 2010, 2001-2008, Bogotá, Ubaté, Manizales, Colombia 13 20.5 103 19.5
Arteaga CE, 2003, 1991-1992, Bogotá, Colombia 0   0.0   37 40.1
Figure 1. Flowchart of the study selection
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Table 2. Description of articles consulted for the literature review
Author, 
publication 
year
Study objective Study 
location
Study type Study period Study 
population
Sample 
size
Outcome 
variable 
definition
Biases
González Y, 
2010
To report 
congenital 
anomalies in 2010
Colombia Routine 
data from 
epidemiologic 
surveillance
2010 Births 654,627 Head 
circumference 
<3 standard 
deviations
Limited to 
coverage of 
the national 
surveillance 
network
González Y, 
2011
To report 
congenital 
anomalies in 2011
Colombia Routine 
data from 
epidemiologic 
surveillance
2011 Births 665,499 Head 
circumference 
<3 standard 
deviations
Limited to 
coverage of 
the national 
surveillance 
network
González Y, 
2012
To report 
congenital 
anomalies in 2012
Colombia Routine 
data from 
epidemiologic 
surveillance
2012 Births 676,835 Head 
circumference 
<3 standard 
deviations
Limited to 
coverage of 
the national 
surveillance 
network
Misnaza SP, 
2013
To report 
congenital 
anomalies in 2013
Colombia Routine 
data from 
epidemiologic 
surveillance
2013 Births 658,835 Head 
circumference 
<3 standard 
deviations
Limited to 
coverage of 
the national 
surveillance 
network
Pachajoa H, 
2010
To evaluate birth 
defects in a tertiary 
care hospital
Cali, 
Colombia
Observational – 
Cross sectional
2004-2008 Births 32,995 Head 
circumference 
<3 standard 
deviations
Small sample 
size
Silva JR, 
1998
To evaluate 
congenital 
malformations 
and genetics 
in a newborn 
population
Barranquilla, 
Colombia
Observational – 
Cross sectional
1987-1988 Live births 3,763 Head 
circumference 
<3 standard 
deviations
Small sample 
size
Ramírez J, 
2015
To evaluate birth 
defects in a tertiary 
care hospital
Cali, 
Colombia
Observational – 
Cross sectional
July, 2011-June, 
2012
Births 5,669 Head 
circumference 
<3 standard 
deviations
Small sample 
size
López JS, 
2015
To evaluate 
microcephaly in 
ECLAMC and in 
Brazil
Colombia Observational – 
Case control
1982-2013 Births 249,746 Head 
circumference 
<3 standard 
deviations
Limited to 
coverage of 
the national 
surveillance 
network
García H, 
2003
To evaluate 
the prevalence 
of congenital 
anomalies at the 
Instituto Materno-
Infantil de Bogotá
Bogotá, 
Colombia
Observational – 
Cross sectional
October, 
1997-April, 
1998, July, 
2000-
November, 
2000
Births 5,686 Head 
circumference 
<3 standard 
deviations
Study 
performed 
during a 
discontinuous 
time period
Porras GL, 
2016
To determine the 
prevalence of 
congenital defects
Risaralda, 
Colombia
Observational – 
Cross sectional
July, 2010- 
December, 
2013
Births 42,431 Head 
circumference 
<3 standard 
deviations
Small sample 
size
Zarante I, 
2010
To determine 
the prevalence 
of congenital 
malformations 
and assess the 
prognosis of 
newborns
Bogotá, 
Ubaté, and 
Manizales, 
Colombia
Observational – 
Cross sectional
April, 
2011-January, 
2008
Births 52,744 Head 
circumference 
<3 standard 
deviations
Small sample 
size
Arteaga CE, 
2003
To assess the 
prevalence and 
factors associated 
with congenital 
anomalies at the 
Instituto Materno-
Infantil de Bogotá
Bogotá, 
Colombia
Observational – 
Cross sectional
1991-1992 Births 9,224 Head 
circumference 
<3 standard 
deviations
Small sample 
size
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3.5 per 10,000 births in 2003. In the period of 
study, the rate of central nervous system  defects in 
Colombia ranged from 2 to 8.7, with microcephaly 
ranging from 0.3 to 3.1 per 10,000 births. On 
average, the prevalence of these defects and 
microcephaly was 23.5 (95% CI 23.1-24) and 1.8 
(95% CI 1.7-1.8) per 10,000 births, respectively. 
The study that reported the highest prevalence 
for microcephaly in the country was by ECLAMC 
during the period 1982-2013. In this study, 24,976 
births were reported, of which 77 were registered 
with microcephaly, leading to a prevalence of 3.08 
per 10,000 births for the follow-up period (table 2).
Discussion
Congenital defects are a worldwide public health 
problem. It is estimated that 7.9 million children 
are born with congenital defects every year, with 
3.3 million children under 5 years of age dying 
due to these defects and 3.2 million surviving 
with disabilities (24). As a cause of infant death in 
Colombia in recent decades, congenital anomalies 
ranked seventh in 1970, fourth in 1980 and third 
in 1994 (25). From 2000 to 2004, a total of 14,036 
deaths from congenital anomalies was reported in 
Colombia, with a mortality rate of 8.43 per 10,000 
births (26). From 2005 to 2011, congenital defects 
were reported as the second leading cause of death 
in children under one year of age, contributing to 
20.8% of all deaths, according to the Departamento 
Administrativo Nacional de Estadísticas (DANE) 
(27). According to the analysis of the health situa-
tion in Colombia, congenital defects are the second 
leading cause of infant mortality. The available 
evidence suggests that the prevalence and the 
potential burden of congenital disorders in public 
health are high in developing countries and, in 
some circumstances, they are greater than in 
developed countries. Birth defects in Colombia are 
responsible for 23% of the total mortality in chil-
dren under 5 years of age (28), a clinically signifi-
cant issue that has been declared a public health 
problem (29).
After the ZV outbreak in the Americas, birth defects 
such as microcephaly have gained particular clini-
cal relevance. Before the epidemic, the definition 
of microcephaly was heterogeneous, controversial, 
and varied between institutions (30). Some authors 
classify microcephaly as a head circumference 
less than two standard deviations from median 
values (31). Other authors suggest that this meas-
ure should be necessarily adjusted to prematurity 
and to the length of patients’ head circumference 
(9,32). Assuming that the cephalic perimeter has 
a normal distribution across the population, 2.3% 
of all children would be defined as having micro- 
cephaly. Despite this, literature estimates that less 
than 0.54% to 0.56% of children are classified 
with a head circumference less than two standard 
deviations, which suggests a non-normal distribu-
tion of this measure (9). The true number of cases of 
microcephaly in Brazil, where the ZV epidemic was 
first associated with the condition, was unknown 
since this event was overestimated, no active 
search was done, and its diagnosis was based on 
non-standardized criteria before the associations 
between Zika and congenital defects (30).
We conducted a systematic review of the litera-
ture regarding the frequency of microcephaly in 
Colombia. The objective was to determine the 
prevalence of microcephaly in the country before 
the ZV epidemic and to establish whether there 
was a change in the prevalence of microcephaly 
per 10,000 births. Such information would allow us 
to determine if the increase of microcephaly cases 
was significant and develop a better approach to 
the Zika virus epidemic in Colombia and its asso-
ciation with congenital defects. 
During the study period, microcephaly was equiv-
alent to 3.38% of congenital defects and its 
prevalence rate fluctuated between 0.3 to 3.1 per 
10,000 live births, with an average rate of 1, 56 per 
10,000 live births from 1982 to 2013. Compared 
with the rate of microcephaly in the rest of Latin 
American countries, Colombia’s rate falls within the 
average since ECLAMC rate per 10, 000 live births 
was 4.53 (95% CI 4.05-5.02) in Brazil and 4.30 
(95% CI 2.57-3.22) in Chile, compared with 3.08 
per 10,000 live births (95% CI 2.04-3.84), which 
does not surpass the global rate of microcephaly 
according to ECLAMC, which was 3.30 (95% CI 
3.09-3.50) per 10,000 live births between 1982 and 
2013. According to ECLAMC, from 1982 to 2013, 
Brazil and Chile had the highest prevalence of 
microcephaly in Latin America (33).
In the study period, few Colombian departments 
and cities had surveillance systems for reporting 
birth defects such as microcephaly. Among the 
studies found in literature, microcephaly, defined 
as a head circumference less than three stan-
dard deviations when adjusted for age and sex, 
we found those from Cali, Barranquilla, Bogotá, 
Risaralda, Manizales, and Ubaté. Besides these 
studies, microcephaly had also been reported in 
articles assessing birth defects across Colombia. 
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This relatively small amount of reporting on 
microcephaly could be explained by the low fre-
quency of the event, which leads to its exclusion 
in the final statistics. Nevertheless, the number of 
reports of congenital malformations has increased 
in recent years, as noted in the annual report of 
Sivigila, which may be explained by an increase 
in reporting or an increase in the rate of micro-
cephaly. We were unable to make this distinction 
in the present study, which represents a limitation. 
Compared to the prevalence of microcephaly 
reported by ECLAMC from 1982 to 2013, the 
prevalence reported by Sivigila from 2010 to 2013 
was lower, with an average prevalence of 1.5 
births with microcephaly per 10,000 births. The 
studies reported and included in this review only 
classified the defects and described the frequency 
of microcephaly, but did not discriminate according 
to etiology. In the present review, we could not find 
any observational cohort studies or case-control 
studies evaluating the risks and other measures of 
association of microcephaly in Colombia. However, 
the different cross-sectional studies reported in 
the country confirmed the existence of micro-
cephaly before the emergence of autochthonous 
ZV in the country.
One limitation of this study was the variability of the 
diagnostic criteria of microcephaly. We used the 
more rigorous criteria, that of less than three stan-
dard deviations of head circumference, adjusted 
for age and sex. Consequently, studies using other 
criteria for microcephaly were not included. Addi-
tionally, it is possible that not all relevant studies 
were found and included in the review, although 
we adopted measures to reduce the likelihood of 
this limitation.
Finally, the prevalence of microcephaly in Colombia 
from 1982 to 2013, before the introduction of ZV, 
ranged from 0.3 to 3.1 per 10,000 births, with an 
average of 1.8 (95% CI 1.7 - 1.8) per 10,000 births. 
These findings are important to determine if the 
prevalence after the introduction of the Zika virus 
has meant significant changes.
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